180 related articles for article (PubMed ID: 12807756)
1. Erythropoietin regulates tumour growth of human malignancies.
Yasuda Y; Fujita Y; Matsuo T; Koinuma S; Hara S; Tazaki A; Onozaki M; Hashimoto M; Musha T; Ogawa K; Fujita H; Nakamura Y; Shiozaki H; Utsumi H
Carcinogenesis; 2003 Jun; 24(6):1021-9. PubMed ID: 12807756
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of erythropoietin signalling destroys xenografts of ovarian and uterine cancers in nude mice.
Yasuda Y; Musha T; Tanaka H; Fujita Y; Fujita H; Utsumi H; Matsuo T; Masuda S; Nagao M; Sasaki R; Nakamura Y
Br J Cancer; 2001 Mar; 84(6):836-43. PubMed ID: 11259101
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma multiforme cells: expression of erythropoietin receptor and response to erythropoietin.
Yin D; Kawabata H; Tcherniamtchouk O; Huynh T; Black KL; Koeffler HP
Int J Oncol; 2007 Nov; 31(5):1193-8. PubMed ID: 17912447
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
[TBL] [Abstract][Full Text] [Related]
5. Targeting the erythropoietin receptor on glioma cells reduces tumour growth.
Pérès EA; Valable S; Guillamo JS; Marteau L; Bernaudin JF; Roussel S; Lechapt-Zalcman E; Bernaudin M; Petit E
Exp Cell Res; 2011 Oct; 317(16):2321-32. PubMed ID: 21749867
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.
Feldman L; Wang Y; Rhim JS; Bhattacharya N; Loda M; Sytkowski AJ
Prostate; 2006 Feb; 66(2):135-45. PubMed ID: 16161153
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of erythropoietin and erythropoietin receptor in tongue squamous cell carcinoma.
Li HG; Li JS; Chen WL; Wang L; Wu DH; Lin ZY
Br J Oral Maxillofac Surg; 2009 Sep; 47(6):470-5. PubMed ID: 19559511
[TBL] [Abstract][Full Text] [Related]
8. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin biology in cancer.
Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
[TBL] [Abstract][Full Text] [Related]
10. The erythropoietin receptor and its expression in tumor cells and other tissues.
Farrell F; Lee A
Oncologist; 2004; 9 Suppl 5():18-30. PubMed ID: 15591419
[TBL] [Abstract][Full Text] [Related]
11. Expression of erythropoietin and its receptor in neuroblastomas.
Sartelet H; Fabre M; Castaing M; Bosq J; Racu I; Lagonotte E; Scott V; Lecluse Y; Barette S; Michiels S; Vassal G
Cancer; 2007 Sep; 110(5):1096-106. PubMed ID: 17647284
[TBL] [Abstract][Full Text] [Related]
12. The role of erythropoietin in regulating angiogenesis.
Kertesz N; Wu J; Chen TH; Sucov HM; Wu H
Dev Biol; 2004 Dec; 276(1):101-10. PubMed ID: 15531367
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
15. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
Um M; Gross AW; Lodish HF
Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma.
Ribatti D; Poliani PL; Longo V; Mangieri D; Nico B; Vacca A
Histopathology; 2007 Apr; 50(5):636-41. PubMed ID: 17394500
[TBL] [Abstract][Full Text] [Related]
17. Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells.
Lifshitz L; Prutchi-Sagiv S; Avneon M; Gassmann M; Mittelman M; Neumann D
Mol Immunol; 2009 Feb; 46(4):713-21. PubMed ID: 19027957
[TBL] [Abstract][Full Text] [Related]
18. Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells.
Acs G; Chen M; Xu X; Acs P; Verma A; Koch CJ
Cancer Lett; 2004 Oct; 214(2):243-51. PubMed ID: 15363551
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation.
Hamadmad SN; Hohl RJ
Biochem Pharmacol; 2007 Aug; 74(4):590-600. PubMed ID: 17586475
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma.
Ribatti D; Marzullo A; Gentile A; Longo V; Nico B; Vacca A; Dammacco F
Histopathology; 2007 Apr; 50(5):591-6. PubMed ID: 17394495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
